RxDoctor Payments Data

Benjamin Winn, PA

Physician Assistant · South West City, MONPI 1629736459

Payments from drug & device makers

$1,791in general payments, 2019–2025

Across 99 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$431
  • AstraZeneca$371
  • Bayer$203
  • Amgen$175
  • Lilly USA, LLC$151
  • Exact Sciences$93
  • plus $367 from 12 others

What the payments were for

  • Food & beverage$1,791100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,791 in reported general payments places this provider in the 80th percentile of 1,380 physician assistant providers in Missouri.

See all physician assistant providers in Missouri

Medicare billing

Part B allowed, 2024
$8,209
Medicare patients
76
Services billed
263

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$23,531
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$16,333
RybelsusSemaglutide11$14,020
GemtesaVibegron17$11,864
FarxigaDapagliflozin Propanediol12$7,430
Omeprazole46$995
Albuterol Sulfate HfaAlbuterol Sulfate55$958
Losartan Potassium65$739
Atorvastatin Calcium81$589
Gabapentin39$549
Levothyroxine Sodium43$544
Ondansetron OdtOndansetron24$486
Fluticasone Propionate28$476
Memantine Hcl20$398
Venlafaxine Hcl ErVenlafaxine Hcl15$380

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBreztri Aerosphere, Farxiga$371$23,76333 claims
Novo NordiskRybelsus$431$14,02011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,380 physician assistant providers in Missouri.

Other physician assistant in South West City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →